Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Nov 2026

Immunologic Timing and Therapeutic Sequencing of Locoregional Therapy and Immunotherapy in Hepatocellular Carcinoma.

Immune checkpoint inhibitor combinations have improved outcomes in hepatocellular carcinoma, but durable benefit remains uneven and the optimal integration of locoregional therapy is unresolved. Local interventions can release tumor antigens, alter vascular and stromal barriers, and recruit innate and adaptive immune c...

Yu-Han Guo, Jian Yu, Yan Jiao · 0 citations
Review Sep 2026

Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease Beyond Fibrosis: Metabolic, Microbial, and Immune Determinants​.

A narrative review evaluates what 'beyond fibrosis' should mean for risk assessment rather than treating fibrosis as dispensable and supports fibrosis-centered, layered risk stratification using clinical factors and noninvasive fibrosis measures.

Zheng-Ying Wang, Cheng-Cheng Song, Yan Jiao · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.